RefBan

Referral Banners

Yashi

Thursday, May 29, 2014

Reuters Health Report

Click to View in Browser
05/29/2014
Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between
Top scientists warn WHO not to stub out e-cigarettes
LONDON (Reuters) - A group of 53 leading scientists has warned the World Health Organization not to classify e-cigarettes as tobacco products, arguing that doing so would jeopardize a major opportunity to slash disease and deaths caused by smoking.
Obama to spotlight risks of head injuries in sports
WASHINGTON (Reuters) - President Barack Obama will host a conference highlighting the risks of head injuries to young athletes on Thursday, seeking to use the power of his office to promote awareness of ways to avoid and treat concussions, White House officials said.
Exclusive: Medicare on drugs: 24,000 tests for 145 patients
NEW YORK (Reuters) - Three Connecticut doctors billed Medicare for nearly 24,000 drug tests in 2012 - on just 145 patients. Despite the extraordinary number, Medicare administrators paid the doctors a total of $1.4 million, according to a Reuters analysis of government payments to health providers.
Weight of the world: 2.1 billion people obese or overweight
WASHINGTON (Reuters) - Obesity is imposing an increasingly heavy burden on the world's population in rich and poor nations alike, with almost 30 percent of people globally now either obese or overweight - a staggering 2.1 billion in all, researchers said on Wednesday.
California lawmakers reject bill requiring labeling on GMO foods
(Reuters) - (This May 28 story was corrected in the seventh paragraph to delete erroneous reference to a genetically modified wheat)
Sanofi, Lilly pursue Cialis over-the-counter approval
NEW YORK (Reuters) - Sanofi and Eli Lilly and Co on Wednesday said they would ask health regulators for permission to sell Cialis, the world's top-selling anti-impotence drug, without a prescription.
Insurers scrutinize drug costs after $84,000 Sovaldi surprise
NEW YORK/LOS ANGELES (Reuters) - Shocked by the rapid adoption of a new $84,000 hepatitis C treatment, U.S. health insurers are trying to make sure they aren't blindsided by other drugs being developed and are looking for ways to limit their use from the day they are launched.
Samsung unveils wristband that can measure health, fitness
SAN FRANCISCO (Reuters) - Samsung Electronics Co Ltd moved deeper into the wearable technology market on Wednesday as it unveiled a wristband that it claims can give a range of real-time health and fitness information.
Top scientists warn WHO not to stub out e-cigarettes
LONDON (Reuters) - A group of 53 leading scientists has warned the World Health Organisation not to classify e-cigarettes as tobacco products, arguing that doing so would jeopardize a major opportunity to slash disease and deaths caused by smoking.
West Africa Ebola outbreak still spreading, 'situation serious': WHO
GENEVA/CONAKRY (Reuters) - Guinea's capital Conakry has recorded its first new Ebola cases in more than a month, while other previously unaffected areas have also reported infections in the past week, according to the World Health Organisation.
Related Video
Researchers see solar-powered cars on the road ahead
Scans reveal snout nervous system of the mighty pliosaur
SUBSCRIBE TO OTHER REUTERS NEWSLETTERS
 Reuters Deals Today
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today  
Reuters Business Today
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today  
» MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter facebook Friend us on Facebook Forward this newsletter to a friend Forward to a friend

No comments:

Yashi

Chitika